SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-031198
Filing Date
2021-03-03
Accepted
2021-03-03 09:55:17
Documents
14
Period of Report
2021-03-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm218561d1_8k.htm   iXBRL 8-K 27028
2 EXHIBIT 99.1 tm218561d1_ex99-1.htm EX-99.1 20595
6 GRAPHIC tm218561d1_ex99-1img01.jpg GRAPHIC 4721
  Complete submission text file 0001104659-21-031198.txt   233292

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20210303.xsd EX-101.SCH 3196
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20210303_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20210303_pre.xml EX-101.PRE 22717
7 EXTRACTED XBRL INSTANCE DOCUMENT tm218561d1_8k_htm.xml XML 3485
Mailing Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355
Business Address 5 GREAT VALLEY PARKWAY SUITE 160 MALVERN PA 19355 484-328-4698
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 21707477
SIC: 2836 Biological Products, (No Diagnostic Substances)